Lung cancer screening

Current Opinion in Pulmonary Medicine

Volumn 11, Issue 4, 2005, Pages 272-277

  McWilliams, Annette ^a   Lam, Stephen ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Computed tomography; Early detection; Lung neoplasms; Screening

Indexed keywords

BIOLOGICAL MARKER; DNA MARKER;

AUTOFLUORESCENCE; BRONCHOSCOPY; CANCER MORTALITY; CANCER SCREENING; COST BENEFIT ANALYSIS; EXPIRED AIR; GENETIC SUSCEPTIBILITY; HUMAN; IMAGING; LUNG CANCER; LUNG NODULE; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM ANALYSIS; TUMOR VOLUME;

BIOLOGICAL MARKERS; BRONCHOSCOPY; HUMANS; LUNG NEOPLASMS; MASS SCREENING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 23044501765     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362:847-852.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29.
3. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321:323-329.
4. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993; 85:457-464.
5. Tong L, Spitz MR, Fueger JJ, et al. Lung cancer in former smokers. Cancer 1996; 78:1004-1010.
6. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000; 92:1308-1316.
7. McWilliams A, MacAulay C, Gazdar AF, et al. Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions. Oncogene 2002; 21:6949-6959.
8. Kato H. Photodynamic therapy for lung cancer-a review of 19 years' experience. J Photochem Photobiol B 1998; 42:96-99.
9. Pasic A, Postmus PE, Sutedja TG. What is early lung cancer? A review of the literature. Lung Cancer 2004; 45:267-277. A review of the clinical, pathologic, and outcome data of early lung cancers in the central airways and peripheral lung that can be treated by local therapy with a high probability of cure.
10. Vonk-Noordegraaf A, Postmus PE, Sutedja TG. Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. Lung Cancer 2003; 39:49-53.
11. Kondo D, Yamada K, Kitayama Y, et al. Peripheral lung adenocarcinomas: 10 mm or less in diameter. Ann Thorac Surg 2003; 76:350-355.
12. Ishiwa N, Ogawa N, Shoji A, et al. Correlation between lymph node micrometastasis and histologic classification of small lung adenocarcinomas in considering the indication of limited surgery. Lung Cancer 2003; 39:159-164.
13. Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003; 76:1016-1022.
14. Patz E, Rossi S, Harpole D, et al. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest 2000; 117:1568-1571.
15. Yanagi S, Sugiura H, Morikawa T, et al. Tumor size does not have prognostic significance in stage IA NSCLC. Anticancer Res 2000; 2092B:1155-1158.
16. Gajra A, Newman N, Gamble GP, et al. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 2003; 42:51-57.
17. Wisnivesky JP, Yankelvitz D, Henschke CI. The effect of tumor size on curability of non-small cell lung cancers. Chest 2004; 126:761-765. A large retrospective review of more than 7500 resected stage I primary NSCLCs evaluating tumor size and correlation with prognosis.
18. Sone S, Li F, Yang Z-G, et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. Br J Radiol 2000; 73:137-145.
19. Henschke CI, Miettinen OS. Women's susceptibility to tobacco carcinogens. Lung Cancer 2003; 43:1-5.
20. Bain C, Feskanich D, Speizer FE, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004; 96:826-834. An analysis of prospective data from two large cohort studies - the Nurses Health Study of Women and the Health Professionals Follow-up Study of Men - evaluating lung cancer rates and relationship to age, gender, and smoking history.
21. Sone S, Yang Z-G, Honda T, et al. Results of three-year mass screening program for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001; 84:25-32.
22. Gazdar AF, Shigematsu HHJ, Minna JD. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? Trends Mol Med 2004; 10:481-486.
23. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304:1497-1500.
24. Henschke C, McCauley D, Yankelevitz D, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999; 354:99-105.
25. Henschke C, Naidich D, Yankelevitz D, et al. Early lung cancer action project: initial findings on repeat screening. Cancer 2001; 92:153-159.
26. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 210:798-802.
27. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association Project. J Clin Oncol 2002; 20:911-920.
28. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165:508-513.
29. Swensen S, Jett J, Hartman T, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003; 226:756-761.
30. Diederich S, Wormanns D, Semik M, et al. Screening For early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002; 222:773-781.
31. Nawa T, Nakagawa T, Kusano S, et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002; 122:15-20.
32. Pastorino U, Bellomi M, Landoni C, et al. Early lung cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362:593-597.
33. McWilliams A, Mayo J, MacDonald S, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003; 168:1167-1173.
34. Henschke CI, Yankelevitz DF, Smith JP, et al. CT screening for lung cancer: assessing a regimen's diagnostic performance. J Clin Imaging 2004; 28:317-321. This paper reports the most recent results of 2968 subjects who underwent baseline and annual repeat screening CT scans as part of the ELCAP-I and ELCAP-II studies.
35. Aberle DR, Black WC, Goldin JG, et al. Experimental design and outcomes of The National Lung Screening Trial (NLST): a multicenter randomized controlled trial of helical CT vs chest-x-ray for lung cancer screening. Am J Respir Crit Care Med 2003; 167:A736.
36. McWilliams A, Mayo J, Ahn MI, et al. Behaviour of screening detected pulmonary nodules [abstract]. Eur Respir J 2004; 24(suppl 48):490S. This abstract discusses long-term follow-up and behavior of more than 2000 screening-detected small pulmonary nodules.
37. Gohagan JK, Marcus PM, Fagerstrom RM, et al. Final results of the lung screening study, a randomized feasibility study of spiral CT versus chest x-ray screening for lung cancer. Lung Cancer 2005; 47:9-15. This study demonstrates that a randomized clinical trial of spiral CT is feasible with a rapid accrual rate and low crossover contamination.
38. Mayo JR, Kim KI, MacDonald S, et al. Reduced radiation dose helical chest CT: effect on reader evaluation of structures and lung findings. Radiology 2004; 232:749-756. An important study to show that lower tube currents can reduce the image quality and affect the diagnostic accuracy of spiral CT.
39. Crestanello JA, Allen MS, Jett JR, et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg 2004; 128:254-259. An updated report of the Mayo Clinic experience on screening CT. The majority of lung nodules were found to be nonmalignant. Eighteen percent of the operations were in subjects with benign disease.
40. Brown MS, Goldin JG, Suh RD, et al. Lung micronodules: automated method for detection at thin-section CT-initial experience. Radiology 2003; 226:256-262.
41. Arimura H, Katsuragawa S, Suzuki K, et al. Computerized scheme for automated detection of lung nodules in low-dose computed tomography images for lung cancer screening. Acad Radiol 2004; 11:617-629. The development of new computer-aided diagnostic software for detection of pulmonary nodules on low-dose screening thoracic CT scans is described, and is applied retrospectively to a screened subject database.
42. Gur D, Zheng B, Fuhrman CR, et al. On the testing and reporting of computer-aided detection results for lung cancer detection. Radiology 2004; 232:5-6.
43. Armato SG III, McLennan G, McNitt-Gray MF, et al. Lung Image Database Consortium: developing a resource for the medical imaging research community. Radiology 2004; 232:739-748.
44. Yankelevitz D, Reeves A, Kostis W, et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217:251-256.
45. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 2000; 174:763-768.
46. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73:1252-1259.
47. Winer-Muram H, Jennings SG, Tarver RD, et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT screening. Radiology 2002; 223:798-805.
48. Watanabe S, Watanabe T, Arai K, et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002; 73:1071-1075.
49. Suzuki K, Asamura H, Kusumoto M, et al. 'Early' peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002; 74:1635-1639.
50. Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 2003; 75:1601-1606.
51. Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004; 44:61-68. A retrospective analysis of 100 subjects with limited resection for primary lung cancer and correlation of outcome with CT characteristics and histopathology.
52. Kishi K, Homma S, Kurosaki A, et al. Small lung tumours with the size of 1 cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung Cancer 2004; 44:43-51. A retrospective review of resected primary lung cancers of ≤1 cm in size, and correlation with pathology and CT findings.
53. Li F, Sone S, Abe H, et al. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol 2003; 10:1013-1020.
54. Pasic A, Brokx HAP, Noordegraaf AV, et al. Cost-effectiveness of early interventions: comparison between intraluminal bronchoscopic treatment and surgical resection for T1N0 lung cancer patients. Respiration (Herrlisheim) 2004; 71:391-396. This is a case-control study of the cost-effectiveness of bronchoscopic treatment versus standard surgical resection in patients with early-stage central bronchial cancers.
55. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004; 231:440-445. An estimation of the risk of radiation-related lung cancer from annual CT screening in the general population age 50 to 75 years.
56. Kostis WJ, Yankelevitz D, Reeves AP, et al. Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 2004; 231:446-452. An important study that determines the shortest time to demonstrate growth reliably in lung nodules of different sizes using state-of-the-art CT scan and volumetric measurement.
57. Becker HD, Herth F, Ernst A, et al. Bronchoscopy biopsy of peripheral lung lesions under electromagnetic guidance: a pilot study. J Bronchol 2005; 12:9-13. This is the first report of an innovative technology that uses CT as a road map and an external magnetic detector to guide insertion of a catheter bronchoscopically to sample peripheral lung nodules in real time.
58. Lafata JE, Simpkins J, Lamerato L, et al. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev 2004; 13:2126-2132. False-positive results from screening is common. The associated medical costs for follow-up testing need to be evaluated.
59. Spitz MR, Wei Q, Dong Q, et al. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 2003; 12:689-698.
60. Xu Z, Wei Q, Wang X, et al. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 2004; 46:1-10.
61. Miller YE, Petty TL, Lam S. The early detection of lung cancer using bronchoscopy and cytologic analysis. In: Lung cancer: principles and practice, 3rd edn. Edited by Pass HI, Carbone DP, Minna JD, et al. Philadelphia: Lippincott Williams & Wilkins; 2005:189-199.
62. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004; 4:707-717. This is a review of the use of methylation biomarkers for lung cancer detection.
63. Phillips M, Cataneo RN, Cummin ARC, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003; 123:2115-2123.
64. Carpagnano GE, Foschino-Barbara MP, Restaa O, et al. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004; 66:180-184. This is another study that demonstrates the potential usefulness of measuring biomarkers in exhaled breath for lung cancer detection.